SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novoste (novt)
NOVT 111.14-6.6%Jan 2 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tktrimbath who wrote (80)10/27/2000 6:28:58 AM
From: Mike   of 100
 
So what is the "word" on the potential for the Beta-cath system? Many unknowns that people are having trouble answering. Can anyone give us a good evaluation of the technology and potential market share the NOVT stent may garner?

Right now many stocks have been "reevaluated" and crushed. From the cardiologists that I have spoken with opinions vary on how good or bad NOVT may do after release. This is where there is either an opportunity to make some serious money or lose it.

Can anyone give us a rundown on what may happen with NOVT once the system has been out three months? By that time we will have a good idea. The only problem is that is four to six months in the future. Let the board know.

Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext